Group 1 - The company has entered into a strategic cooperation framework agreement with BGI CoWin to establish an innovative drug intellectual property tokenization fund [1] - The fund will invest in projects under the NewCo+RWA Web3 exchange ecosystem model in Hong Kong, the United States, or other overseas regions [1] - BGI CoWin will act as the general partner responsible for managing the NewCo innovative drug RWA fund, while the company will contribute as a limited partner [1] Group 2 - The strategic cooperation aims to enhance the company's business layout through a tripartite strategy of "NewCo+RWA+stablecoin" [2] - This collaboration is expected to strengthen the company's role in reshaping the global medical innovative drug asset value chain [2]
华检医疗拟与华大共赢共同建立华检华大共赢创新药知识产权代币化基金